Literature DB >> 11506743

Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta.

E J Bartholomé1, I Van Aelst, E Koyen, R Kiss, F Willems, M Goldman, G Opdenakker.   

Abstract

We studied the secretion of gelatinase B by dendritic cells (DC) generated by culturing human peripheral blood monocytes in granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). First, we found the intracellular expression of gelatinase B on sections of fixed DC pellets. Zymography analysis of the supernatants of DC cultured for 72 h demonstrated the presence of gelatinase B. To determine if DC produce net enzymatic activity, bioactive gelatinase, a novel sensitive fluorescent-activated substrate conversion (FASC) assay was used to complement the zymography data. Culture media of unstimulated DC demonstrated reproducible net gelatinolytic activity. Tumor necrosis factor-alpha (TNF-alpha) IL-1beta but not lipopolysaccharide (LPS) stimulation caused a significant increase in gelatinase B production in zymography analysis. Both types of stimulation failed to increase net gelatinase activity in FASC assay. Interestingly, interferon-beta (IFN-beta) significantly diminished both the total zymolytic production and the net bioactive gelatinase produced by DC in a dose-dependent manner. We conclude that human monocyte-derived DC secrete bioactive gelatinase B and that IFN-beta inhibits this production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506743     DOI: 10.1089/10799900152434367

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  11 in total

1.  MMP-9 gene variants increase the risk for non-atopic asthma in children.

Authors:  Leonardo A Pinto; Martin Depner; Norman Klopp; Thomas Illig; Christian Vogelberg; Erika von Mutius; Michael Kabesch
Journal:  Respir Res       Date:  2010-02-24

2.  PGE2-induced metalloproteinase-9 is essential for dendritic cell migration.

Authors:  Jui-Hung Yen; Tanzilya Khayrullina; Doina Ganea
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

Review 3.  Targeting MMPs in acute and chronic neurological conditions.

Authors:  V Wee Yong; Smriti M Agrawal; David P Stirling
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

4.  Infection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability.

Authors:  Delphine Marsac; Stephanie García; Alexandra Fournet; Adam Aguirre; Karla Pino; Marcela Ferres; Alexis M Kalergis; Marcelo Lopez-Lastra; Francisco Veas
Journal:  Virol J       Date:  2011-05-13       Impact factor: 4.099

Review 5.  The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas.

Authors:  Helen Könnecke; Ingo Bechmann
Journal:  Clin Dev Immunol       Date:  2013-08-14

Review 6.  Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development.

Authors:  Elżbieta Bronisz; Iwona Kurkowska-Jastrzębska
Journal:  Mediators Inflamm       Date:  2016-12-26       Impact factor: 4.711

Review 7.  Anti-inflammatory properties of Type I interferons.

Authors:  Alfons Billiau
Journal:  Antiviral Res       Date:  2006-04-04       Impact factor: 5.970

8.  Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.

Authors:  Nele Berghmans; Hubertine Heremans; Sandra Li; Erik Martens; Patrick Matthys; Lydia Sorokin; Jo Van Damme; Ghislain Opdenakker
Journal:  J Neuroinflammation       Date:  2012-10-25       Impact factor: 8.322

9.  Inhibition of myelin-cleaving poteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II.

Authors:  Tiziana Latronico; Maria Teresa Branà; Pasqua Gramegna; Anna Fasano; Gaetano Di Bari; Grazia Maria Liuzzi
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

Review 10.  To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis.

Authors:  Maxime De Laere; Zwi N Berneman; Nathalie Cools
Journal:  J Neuropathol Exp Neurol       Date:  2018-03-01       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.